Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement

JAMA. 2021 Apr 13;325(14):1436-1442. doi: 10.1001/jama.2021.3069.

Abstract

Importance: Vitamin D is a fat-soluble vitamin that performs an important role in calcium homeostasis and bone metabolism and also affects many other cellular regulatory functions outside the skeletal system. Vitamin D requirements may vary by individual; thus, no one serum vitamin D level cutpoint defines deficiency, and no consensus exists regarding the precise serum levels of vitamin D that represent optimal health or sufficiency.

Objective: To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on screening for vitamin D deficiency, including the benefits and harms of screening and early treatment.

Population: Community-dwelling, nonpregnant adults who have no signs or symptoms of vitamin D deficiency or conditions for which vitamin D treatment is recommended.

Evidence assessment: The USPSTF concludes that the overall evidence on the benefits of screening for vitamin D deficiency is lacking. Therefore, the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults cannot be determined.

Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (I statement).

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Asymptomatic Diseases
  • Humans
  • Mass Screening* / adverse effects
  • Mass Screening* / methods
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D / therapeutic use
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / diagnosis*
  • Vitamin D Deficiency / drug therapy
  • Vitamins / therapeutic use

Substances

  • Vitamins
  • Vitamin D
  • 25-hydroxyvitamin D